Karie D. Runcie, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Talimogene Laherparepvec (T-VEC) in Pancreatic Cancer (NCT03086642) | Karie D. Runcie, MD | 2017-11-16 |
Track Karie D. Runcie, MD automatically
Every clearance here is in the API, with alerts when new ones post.